Verastem is a startup based in the United States, most recent round Series-c-plus, 1 tracked investor.
Verastem is a startup based in the United States. Its most recent tracked round is Series-c-plus. Brouky records 1 investor associated with the company.
Verastem is a biopharmaceutical company focused on discovering and developing novel drugs that selectively target cancer stem cells.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.